<DOC>
	<DOCNO>NCT02710721</DOCNO>
	<brief_summary>The aim trial first evaluation effectiveness intermittent fast supplementary therapy patient CRPC hormone-sensitive prostate cancer high metastatic load ( 1≥ visceral ≥4 osseous metastasis ) respect quality life , reduction side effect possible reduction tumor progression .</brief_summary>
	<brief_title>Fasting Nutritional Therapy Patients With Advanced Metastatic Prostate Cancer</brief_title>
	<detailed_description>Prostate cancer Germany approximately 25 % cancer common cancer among man . Assumably increase prostate cancer next year demographic factor . The progressive metastatic prostate cancer often develop androgen resistance . This so-called Castration-Resistant Prostate Cancer ( CRPC ) responsive androgen deprivation therapy . Depending symptoms progression first-line chemotherapy - docetaxel abiraterone available . Intermittent fast form caloric restriction study extensively experimentally recent year . It show consistent beneficial effect relevant inflammatory oncological pathway . In field preclinical oncology research group recently focus intermittent fast chemotherapeutic treatment promise experimental data publish . In summary , combination fast chemotherapy effective various cancer animal model chemotherapy alone .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Diagnosis CRPC hormonesensitive prostate cancer high metastatic load ( 1≥ visceral ≥4 osseous metastasis ) Cancer treat guideline conventionally chemotherapy combination hormone therapy chemotherapy . Underweight ( BMI &lt; 20 kg/m2 ) actual weight decrease &gt; 2 kg &gt; 5 kg last 1 3 month . Eating disorder Dementia Psychosis Terminal illness significant limitation mobility overall vitality Diabetes mellitus type 1 Renal insufficiency stage &gt; 2 , GFR &lt; 60mlmin / 1.73 m2</criteria>
	<gender>Male</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Fasting</keyword>
	<keyword>Prostatic Neoplasms</keyword>
	<keyword>Complementary Therapies</keyword>
	<keyword>Urology</keyword>
</DOC>